Mr Stockboy, If AMRN can gain ground over generics without partnering, then
that would make sense. However, if AMRN were to conclude that authorized
generic sales would surge by partnering with a generic, then that would have to
get serious consideration. Generics offer packages of drugs. AMRN only would
have the one if they went AG. Of course management is not going to do anything
with the US market to impair a potential BO. (Or so we hope!) The script numbers
Capt Beer reported last Friday were very encouraging. I hope that becomes a
trend.
News 
Market Data 
Discover 
